Correlation Between Alvarium Tiedemann and Catalyst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Alvarium Tiedemann and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alvarium Tiedemann and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alvarium Tiedemann Holdings and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on Alvarium Tiedemann and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alvarium Tiedemann with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alvarium Tiedemann and Catalyst Pharmaceuticals.
Diversification Opportunities for Alvarium Tiedemann and Catalyst Pharmaceuticals
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Alvarium and Catalyst is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Alvarium Tiedemann Holdings and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and Alvarium Tiedemann is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alvarium Tiedemann Holdings are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of Alvarium Tiedemann i.e., Alvarium Tiedemann and Catalyst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Alvarium Tiedemann and Catalyst Pharmaceuticals
Given the investment horizon of 90 days Alvarium Tiedemann is expected to generate 3.84 times less return on investment than Catalyst Pharmaceuticals. In addition to that, Alvarium Tiedemann is 1.76 times more volatile than Catalyst Pharmaceuticals. It trades about 0.02 of its total potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about 0.11 per unit of volatility. If you would invest 1,551 in Catalyst Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 656.00 from holding Catalyst Pharmaceuticals or generate 42.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alvarium Tiedemann Holdings vs. Catalyst Pharmaceuticals
Performance |
| Timeline |
| Alvarium Tiedemann |
| Catalyst Pharmaceuticals |
Alvarium Tiedemann and Catalyst Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alvarium Tiedemann and Catalyst Pharmaceuticals
The main advantage of trading using opposite Alvarium Tiedemann and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alvarium Tiedemann position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.| Alvarium Tiedemann vs. Allient | Alvarium Tiedemann vs. Avis Budget Group | Alvarium Tiedemann vs. Playtika Holding Corp | Alvarium Tiedemann vs. Arrow Electronics |
| Catalyst Pharmaceuticals vs. Day One Biopharmaceuticals | Catalyst Pharmaceuticals vs. Terns Pharmaceuticals | Catalyst Pharmaceuticals vs. X4 Pharmaceuticals | Catalyst Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |